Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Cancer Genetics and Cytogenetics|December 14, 2004
Global hypomethylation is common in prostate cancer cells: a quantitative predictor for clinical outcome?Arthur R Brothman, Gregory Swanson, Teresa M Maxwell, et al.
Cancer|October 1, 1991
Prostate-specific antigen levels from completely sectioned, clinically benign, whole prostatesP N Brawn, V O Speights, D Kuhl, et al.
Cancer|April 15, 1993
Stage at presentation and survival of white and black patients with prostate carcinomaP N Brawn, E H Johnson, D L Kuhl, et al.
Personalized Medicine|May 16, 2018
TRIG on TRACK: educating pathology residents in genomic medicineRichard L Haspel, James B Atkinson, Frederic G Barr, et al.
Urology|July 1, 1994
Characteristics of prostatic infarcts and their effect on serum prostate-specific antigen and prostatic acid phosphataseP N Brawn, D M Foster, D W Jay, et al.
The Prostate|May 1, 1996
Prostatic acid phosphatase levels (enzymatic method) from completely sectioned, clinically benign, whole prostatesP N Brawn, D W Jay, D M Foster, et al.
Cancer|June 12, 2009
Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapyGuru Sonpavde, Bryan H Goldman, V O Speights, et al.
The Journal of Urology|March 21, 1998
Computer modeling of prostate biopsy: tumor size and location--not clinical significance--determine cancer detectionE D Crawford, D Hirano, P N Werahera, et al.
Archives of Neurology|November 1, 1986
Myopathy and fatal cardiopathy due to cytochrome c oxidase deficiencyM Zeviani, D H Van Dyke, S Servidei, et al.
The New England Journal of Medicine|August 29, 2003
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancerH Barton Grossman, Ronald B Natale, Catherine M Tangen, et al.
Pageof 8